Dr Arnaud Delobel is the R&D and Innovation Director at Quality Assistance, where he leads analytical development strategies for biopharmaceutical products, including vaccines, monoclonal antibodies, and gene therapies. 

He holds a PhD in analytical chemistry and has over two decades of experience in mass spectrometry, chromatography, and the development of regulatory-driven methods. At Quality Assistance, his mission is to ensure the continuous adoption of state-of-the-art analytical approaches. He leads scientific, technological, and regulatory intelligence efforts and drives the implementation of innovative analytical technologies and workflows, enabling the company to effectively support pharmaceutical partners in the development of their most advanced therapeutic products.